Vicinitas Therapeutics Email Format

Biotechnology ResearchCalifornia, United States2-10 Employees

Vicinitas Therapeutics is a biotechnology company focused on targeted protein stabilization using Deubiquitinase Targeting Chimeras (DUBTACs). It aims to address proteins that are abnormally degraded in diseases such as cancer and monogenic disorders, including proteins previously considered undruggable. The company originated from a collaboration between Novartis Institutes for BioMedical Research and the University of California, Berkeley, and is based in South San Francisco, California, with a website at vicinitastx.com. It operates with a small team of 2-10 employees. Reported revenue is between $0 and $1 million.

Sign up for free to view info

Company overview Employee directory